Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis
NCT01799824 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2013-12-10
Summary
The purpose of this study is to confirm the effect of ANT-1403 in the treatment of primary axillary hyperhidrosis.
Conditions
- Primary Axillary Hyperhidrosis
Interventions
- BIOLOGICAL
-
ANT-1403
- BIOLOGICAL
Sponsors & Collaborators
-
Anterios Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis
NCT03627468 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
NCT07301203 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD
NCT06003049 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
NCT06603246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175
NCT05628740 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
NCT02482324 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.
NCT01587716 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, First-in-human Study of VX-634
NCT05579431 ·Status: COMPLETED ·Phase: PHASE1
-
Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD
NCT00860938 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 1, First-in-human Study of VX-668
NCT05727800 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
NCT04139915 ·Status: WITHDRAWN ·Phase: PHASE3
-
Sodium Pyruvate Therapy in COPD Patients
NCT00262613 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects
NCT01494636 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
NCT03502902 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
NCT04472494 ·Status: TERMINATED ·Phase: PHASE2
-
ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
NCT03638063 ·Status: UNKNOWN
-
A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers
NCT02198313 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects
NCT01994109 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness
NCT03137992 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
NCT03373903 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19
NCT04771000 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
NCT03830125 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
NCT01597635 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00581945 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172391 ·Status: COMPLETED ·Phase: PHASE3